期刊文献+

普朗尼克F68对地西泮在小鼠血浆和脑组织中浓度的影响 被引量:1

Effect of Pluronic F68on plasma and brain diazepam concentrations in mice
下载PDF
导出
摘要 药用辅料作为药物制剂中不可缺少的组分,通常被认为是惰性物质。非离子型表面活性剂普朗尼克(pluronic)常用来增加难溶性药物在水中的溶解度和改善难溶性药物在体内生物利用度差等问题,但有研究表明,普朗尼克对某些药物的转运与吸收具有一定的影响。因此,研究普朗尼克对药物在体内的吸收与分布的影响具有重要意义。
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第12期1388-1390,共3页 Academic Journal of Second Military Medical University
关键词 普朗尼克F68 地西泮 血浆浓度 脑组织浓度 Pluronie F68 diazepam plasma concentration brain concentration
  • 相关文献

参考文献6

  • 1黄建耿,斯陆勤,左克源,吴祥根,裘军,李高.普朗尼克抑制P-糖蛋白药泵的作用[J].药学学报,2007,42(9):989-994. 被引量:7
  • 2Johnson B M,Charman W N? Porter C J. An in vitro examina-tion of the impact of polyethylene glycol 400,Pluronic P85,andvitamin E d-alpha-tocopheryl polyethylene glycol 1 000 succi-nate on P-glycoprotein efflux and enterocyte-based metabolismin excised rat intestine[J]. AAPS Pharm Sci,2002,4:193-205.
  • 3Foger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnurch A. In vivo comparison of various polymeric and lowmolecular mass inhibitors of intestinal P-glycoprotein [J ]. Bio-materials,2006 ,27:5855-5860.
  • 4Batrakova E V,Li S,Alakhov V Y,Miller D W,Kabanov A V.Optimal structure requirements for pluronic block copolymers inmodifying P-glycoprotein drug efflux transporter activity in bo-vine brain microvessel endothelial cells[J]. J Pharmacol Exp T-her,2003,304:845-854.
  • 5Ma L, Wei Y,Zhou Y,Ma X* Wu X. Effects of Pluronic F68 andLabrasol on the intestinal absorption and pharmacokinetics ofrifampicin in rats[J]. Arch Pharm Res,2011,34 : 1939-1943.
  • 6Yamazaki M,Neway W E,Ohe T,Chen I,Rowe J F, Hochman JH,et al. In vitro substrate identification studies for p-glycopro-tein-mediated transport: species difference and predictability ofin vivo results[J]. J Pharmacol Exp Ther, 2001,296 : 723-735.

二级参考文献10

  • 1胡一桥,郑梁元,钱陈钦,郁伟海.离子型药物酚红的小肠吸收研究[J].中国药科大学学报,1996,27(6):355-359. 被引量:56
  • 2韩旻,韩丽妹,王青松,白志华,方晓玲.三七皂苷的口服吸收机制[J].药学学报,2006,41(6):498-505. 被引量:45
  • 3田莉,杨秀伟,王莹,徐嵬.顺式-和反式-阿霍烯在Caco-2细胞模型中的体外摄取、转运和外排特性[J].药学学报,2007,42(1):87-92. 被引量:7
  • 4Camenisch G,Folkers G,Waterbeemd H.Comparison of passive drug transport through Caco-2 cells and artificial membranes[J].Int J Pharm,1997,147:61-70.
  • 5Tetao T,Hisanaga E,Sai Y,et al.Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier[J].J Pharm Pharmacol,1996,48:1083-1089.
  • 6Cornair G,Woodley J,Hermann P,et al.Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo[J].Int J Pharm,2004,278:119-131.
  • 7Yee S.In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth[J].Pharm Res,1997,14:763-766.
  • 8Varma MV,Ashokraj Y,Dey CS,et al.P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement[J].Pharm Res,2003,48:347-359.
  • 9Walle UK,Walle T.Taxol transport by human intestinal epithelial Caco-2 cells[J].Drug Metab Dispos,1998,26:343-346.
  • 10Sutton CS,Rinaldi MT,Vukovinsky KE,et al.Comparison of the gravimetric,phenol red,and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model[J].AAPS Pharm Sci,2001,3:25-29.

共引文献6

同被引文献27

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部